Response from Professor Ian Wilkinson and Professor Professor Philip Chowienczyk regarding the recent publication of a trial among high-risk hypertensive patients.

The trial suggested a BP target of <120 mm Hg, as compared with <140 mm Hg, prevents major vascular events, with minimal excess risk (Liu J et.al. Lancet 2024, https://doi.org/10.1016/S0140-6736(24)01028-6)